Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2015JNCI Journal of the National Cancer InstituteOpen Access

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories: Table 1.

View Full Paper
Ask AI
Bookmark
Share

Authors

VRVictoria M. RaymondGuardant (United States)SGStacy W. GrayCity Of Hope National Medical CenterSRSameek RoychowdhuryThe Ohio State University Wexner Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Raymond et al. (2015) studied this question.

synapsesocial.com/papers/6a036d53fa5543cdbf696f9ehttps://doi.org/10.1093/jnci/djv351
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data2010 · 30,766 citations
  2. 2Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs2012 · 1,815 citations
  3. 3Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA22003 · 2,248 citations
  4. 4Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study2011 · 639 citations